Crinetics Pharmaceuticals Inc (CRNX)
Healthcare
Biotechnology
83.50 $
-0.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Crinetics Pharmaceuticals Inc (CRNX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -125 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -46 | -41 | -39 | -53 | -48 | -61 | -65 | -88 | -86 | -111 | -93 | -125 | -414 | |
| 0.3 | 0.3 | 0.3 | 0.5 | 0.8 | 0.8 | 0.8 | 0.9 | 1.0 | 1.0 | 1.0 | 1.2 | 4.1 | |
| 10 | 11 | 12 | 13 | 19 | 18 | 19 | 20 | 26 | 23 | 22 | 30 | 100 | |
| 9.4 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -4.4 | 4.9 | 8.3 | 2.7 | 9.4 | -0.1 | -0.3 | -9.5 | 6.6 | -1.5 | 9.3 | -26 | -12 | |
| 0.2 | 3.5 | 0.9 | 1.3 | 1.0 | 0.5 | 1.0 | 1.2 | 3.2 | 0.9 | 0.5 | 0.8 | 5.3 | |
| 31 | -193 | -87 | 0.3 | -54 | 21 | -542 | -86 | 38 | 165 | 57 | -252 | 7.5 | |
| – | – | – | – | – | – | – | 0.0 | – | – | – | -0.6 | – | |
| 13 | 338 | 38 | 394 | 7.5 | 55 | 554 | 4.4 | 7.1 | 3.1 | 26 | 390 | 426 | |
| -1.6 | 103 | -88 | 341 | -94 | 15 | -53 | -170 | -41 | 57 | -9.9 | 13 | 19 | |
| -46 | -45 | -39 | -54 | -49 | -61 | -66 | -90 | -89 | -112 | -93 | -126 | -420 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.